Round table on CRISPR Babies in China
Event details
| Date | 30.11.2018 |
| Hour | 11:00 › 12:00 |
| Speaker | Didier Trono, Roger G Clerc, Marie-Valentine Florin, Kenneth Oye |
| Location | |
| Category | Conferences - Seminars |
This week, Chinese scientist He Jainkui announced the birth of the first genetically tailored humans using the gene editing. We are happy to invite to a panel discussion on this specific case and on long-term issues that it raises for science and policy.
- What was claimed and what was actually done in China ? [Didier Trono]
- What is the medical significance and ethical propriety? [Roger G. Clerc]
- What risk, governance and consent issues are associated? [Marie-Valentine Florin]
- What are the short and long-term policy implications? [Kenneth Oye]
Short bios of the panelists:
Didier Trono, MD, is a Professor for genetics and virology at EPFL and helps stir the Swiss efforts towards exploiting new technologies in the field of health. Once focused on HIV/AIDS and gene therapy, his research is now exploring how epigenetics is shaping human biology and how its understanding can open new avenues in medicine.
Roger G Clerc, PhD, is a Professor for molecular biology and epigenetics at the Biozentrum University of Basel and a former Hoffmann la Roche principal scientist in metabolic disease area.
Marie-Valentine Florin is the Executive Director of the EPFL International Risk Governance Center, a multi-stakeholder platform and a convening place at the interface between science and policy.
Kenneth Oye, PhD, is a Professor in social sciences and engineering and Director of the Program on Emerging Technologies at MIT. He is a research affiliate of the Synthetic Biology Center, the Center for Biomedical Innovation and the Broad Institute Foundry.
Practical information
- Informed public
- Free
- This event is internal
Organizer
- Kenneth Oye
Contact
- Eva Schier